Source:http://linkedlifedata.com/resource/pubmed/id/11144993
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2000-12-28
|
pubmed:abstractText |
The authors have studied 10 critically ill patients with acute respiratory distress syndrome who required a neuromuscular blocking drug to assist mechanical ventilation. Patients received a bolus dose of 1 mg/kg of atracurium followed by a constant infusion rate of 1 mg/kg/h of this drug for 72 hours. Neuromuscular block was monitored using an accelerograph. Blood samples were obtained over a 96-hour period. A preliminary independent analysis was done to estimate the individual pharmacokinetic parameters; data were consistent with a one-compartment model. The pharmacodynamic data analysis was then performed using the changes in train-of-four (TOF) count as an index of the therapeutic effect of atracurium. Pharmacokinetic-dynamic variables were calculated using the Sheiner model and the Hill equation. The elimination half-life of atracurium averaged 22 minutes. Mean volume of distribution and plasma clearance were 217 ml/kg and 550 ml/min, respectively. There was a significant hysteresis loop when the TOF count was plotted against predicted plasma atracurium concentrations. The mean sigmoidicity factor, gamma, was 4.04. The concentration producing 50% of the Emax was 1.36 micrograms/mL, and the mean ke0 was 0.059 min-1. Recovery time ranged from 30 to 80 minutes, and none of the patients of this study had residual paralysis.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0091-2700
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
41
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
44-50
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:11144993-Adult,
pubmed-meshheading:11144993-Aged,
pubmed-meshheading:11144993-Aged, 80 and over,
pubmed-meshheading:11144993-Atracurium,
pubmed-meshheading:11144993-Critical Illness,
pubmed-meshheading:11144993-Drug Administration Schedule,
pubmed-meshheading:11144993-Humans,
pubmed-meshheading:11144993-Infusions, Intravenous,
pubmed-meshheading:11144993-Isoquinolines,
pubmed-meshheading:11144993-Middle Aged,
pubmed-meshheading:11144993-Models, Biological,
pubmed-meshheading:11144993-Neuromuscular Nondepolarizing Agents,
pubmed-meshheading:11144993-Respiration, Artificial,
pubmed-meshheading:11144993-Respiratory Distress Syndrome, Adult
|
pubmed:year |
2001
|
pubmed:articleTitle |
Pharmacokinetic-pharmacodynamic modeling of atracurium in intensive care patients.
|
pubmed:affiliation |
Laboratoire de Pharmacocinétique Clinique, Faculté de Pharmacie 34060 Montpellier, France.
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|